The elites vs the rest: can trust barometers predict political disruption?

Be careful what you wish for: cancer innovation and drug pricing

Brexit has gone to the dogs

The NHS 10-year plan: more artificial intelligence, less pigeon resuscitation

Targets, takeovers and Tomb Raiders: things to watch in 2019 global health policy

Recognition where it’s due: the Access to Medicines Index and the pharma industry

Brexit, Britain and belly laughs: reflections of an Australian political tragic*

Crouching dragons and hidden tigers: the emergence of China’s life sciences sector

My failure as a Rockstar: lessons from technological change in the music industry

Universal health coverage and health technology assessment in Sub-Saharan Africa

Doing it for Jane: eradicating tuberculosis

Access Accelerated: NCDs and the pharmaceutical industry’s coming of age

Black swans, disruption and dealing with the unexpected: lessons from the 17th century

Building the dream or living in la-la land? – PBS reform 10 years on

Can we handle a cure?: the politics and economics of hepatitis C treatment

The NHS – what lessons from a 70-year-old system of universal health coverage?

To price or not to price, that is the question

Don't forget the future: Alzheimer's disease and the economics of drug development

World Health Assembly: a change in the air?

Anti-vaxxers should read Roald Dahl